 Therefore, several clinical trials using passive and active immunization approaches by development of certain drugs approved by the FDA are currently underway, and are expected to yield results in a couple of years.The implementation of these drugs is during the onset of AD.Other research and drug development for early intervention and AD prevention is ongoing.